Psychedelics
Many currently or formerly controlled substances, such as MDMA, psilocybin, cannabis, ketamine, LSD and others, have shown immense promise as therapeutic treatments for a range of mental health disorders. Here's the latest research and findings in psychedelic and next-gen medicine.
Top News
-
While CBD or cannabidiol is now widely available, widely used and generally considered safe, new research has found its use during pregnancy may produce some strange behavior in offspring and changes to the way their brains process sensory information. -
Citizen scientists have been key to the discovery of two new species of hallucinogenic fungi, joining the ranks of 140 known types of these psychoactive mushrooms. One even has longstanding roots in traditional healing medicine in mountainous Lesotho. -
After comparing the long-term effects of the psychedelic psilocybin and a commonly prescribed antidepressant, new research found that both significantly reduced depression. However, psilocybin provided something more: a significant boost to quality of life.
Load More
Latest News
-
April 03, 2025 | Rich HaridyA landmark clinical trial testing the effect of microdosing LSD on symptoms of ADHD recently delivered its first data readout and the results have been surprising, to say the least, raising questions over the efficacy of this popular trend. -
March 20, 2025 | Michael FrancoThe cannabis-derived compound cannabidiol is gaining traction as a treatment for a multiple conditions, but it's notoriously hard for the body to use. Now a breakthrough production method has removed a major roadblock to its bioavailability. -
September 13, 2024 | Paul McClureA poll of Americans aged 50 and over on their use of cannabis has provided some interesting insights into how often they use the drug, how and why they use it, and the behaviors they engage in while under the influence. -
August 15, 2024 | Abhimanyu GhoshalWe were this close to seeing Ecstasy being incorporated into therapy in the US in 2024. Now, we have to wait either a little or a lot – depending on how the chips fall. Let's have a closer look at where we're currently at. -
June 24, 2024 | Paul McClureA slow-release, twice-a-week ketamine tablet significantly reduced depression symptoms, according to the results of a clinical trial. The tablet can be taken at home without medical supervision, making it more convenient than current ketamine treatments. -
March 19, 2024 | Paul McClureLaws are opening up to support the use of medicinal psilocybin – and that requires new technology to ensure accurate, consistent dosing. Researchers have now developed a fast and reliable method of determining the potency of magic mushrooms. -
February 19, 2024 | Paul McClureNew research has found that daily users of crystal methamphetamine who turned to cannabis to manage their cravings used the stimulant drug less, especially female users. The findings suggest a new harm-reduction strategy is needed. -
February 08, 2024 | Paul McClureA study has found that a cannabis extract can inhibit the growth of melanoma cells and trigger cell death. The next step is pre-clinical trials to investigate whether the extract can be used to treat other types of cancers. -
January 16, 2024 | Paul McClureResearchers have uncovered a brain mechanism that causes 'the munchies' after cannabis use, paving the way for therapeutics to treat appetite disorders like anorexia and obesity and to improve the appetite of patients undergoing cancer treatment. -
January 15, 2024 | Paul McClureA new study has found that there was no association between using cannabis and non-medical opioid use in people receiving pharmacotherapy for opioid use disorder. The findings neither confirm that using cannabis leads to opioid use nor that it's effective in reducing it. -
December 19, 2023 | Bronwyn ThompsonAn effective single-dose, long-term treatment for anxiety could be within reach, with the phase 2b clinical trial of MM-120 reported to have passed the stage with flying colors. -
December 18, 2023 | Paul McClureA clinical trial has demonstrated that psilocybin-assisted therapy is effective at treating depression in patients with cancer. In a first, the drug was given to small groups of patients simultaneously, before they underwent one-on-one and group therapy. -
December 04, 2023 | Paul McClureResearchers have revealed how regular ketamine use produces divergent changes in parts of the brain that produce the ‘feel-good’ neurotransmitter, dopamine. The discovery could have significant implications for the treatment of mental illness. -
November 13, 2023 | Paul McClureA new study has found that a majority of medical cannabis users suffering from insomnia and poor-quality sleep are ditching conventional over-the-counter and prescription sleep aids in favor of using the drug to treat sleep-related problems. -
October 19, 2023 | Paul McClureA study into using ketamine to treat depression has yielded surprising results. Despite the unique way in which the researchers ensured the trial was ‘blind’, the placebo and treatment groups had the same improvement in symptom severity.
Load More